Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via nf-κb regulated ATM expression

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ma, Xiaoqian ^a,d   Yang, Lifang ^a,b   Xiao, Lanbo ^a   Tang, Min ^a   Liu, Liyu ^a   Li, Zijian ^a   Deng, Mengyao ^a   Sun, Lunquan ^b,d   Cao, Ya ^a,c,d  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; SMALL INTERFERING RNA; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; CELL CYCLE PROTEIN; DEOXYRIBOZYME; DNA BINDING PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; NITRILE; PROTEIN SERINE THREONINE KINASE; SULFONE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR MECHANICS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RADIOSENSITIVITY; RADIOSENSITIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOCHEMISTRY; METABOLISM; NASOPHARYNX TUMOR; NUDE MOUSE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING; X RAY;

HUMAN HERPESVIRUS 4; MUS;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA, CATALYTIC; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; NITRILES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SULFONES; TUMOR SUPPRESSOR PROTEINS; VIRAL MATRIX PROTEINS; X-RAYS;

EID: 80655132010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024647     Document Type: Article

References (45)

1. Shiloh Y, (2001) ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem Soc Trans 29: 661-666.
2. Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, et al. (2003) ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet 145: 115-120.
3. Roy K, Wang L, Makrigiorgos GM, Price BD, (2006) Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun 344: 821-826.
4. Pandita TK, Pathak S, Geard CR, (1995) Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet Cell Genet 71: 86-93.
5. Allio T, Preston RJ, (2000) Increased sensitivity to chromatid aberration induction by bleomycin and neocarzinostatin results from alterations in a DNA damage response pathway. Mutat Res 453: 5-15.
6. Nabel GJ, Verma IM, (1993) Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev 7: 2063.
7. Baeuerle PA, Henkel T, (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-179.
8. Orlowski RZ, Baldwin AS Jr, (2002) NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385-389.
9. Fan M, Ahmed KM, Coleman MC, Spitz DR, Li JJ, (2007) Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells. Cancer Res 67: 3220-3228.
10. Li Z, Xia L, Lee LM, Khaletskiy A, Wang J, et al. (2001) Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat Res 155: 543-553.
11. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, et al. (2003) Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23: 2362-2378.
12. Hammarskjold ML, Simurda MC, (1992) Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J Virol 66: 6496-6501.
13. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM, (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267: 24157-24160.
14. Dudziak D, Kieser A, Dirmeier U, Nimmerjahn F, Berchtold S, et al. (2003) Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway. J Virol 77: 8290-8298.
15. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, et al. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. Embo J 16: 6478-6485.
16. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS, (1999) Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 274: 16085-16096.
17. Gires O, Kohlhuber F, Kilger E, Baumann M, Kieser A, et al. (1999) Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. Embo J 18: 3064-3073.
18. Lu ZX, Ye M, Yan GR, Li Q, Tang M, et al. (2005) Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther 12: 647-654.
19. Lu ZX, Ma XQ, Yang LF, Wang ZL, Zeng L, et al. (2008) DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett 265: 226-238.
20. Yan Z, Yong-Guang T, Fei-Jun L, Fa-Qing T, Min T, et al. (2004) Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1. Int J Biochem Cell Biol 36: 1473-1481.
21. Ding L, Li LL, Yang J, Tao YG, Ye M, et al. (2005) Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. Int J Biochem Cell Biol 37: 1881-1889.
22. Deng L, Yang J, Zhao XR, Deng XY, Zeng L, et al. (2003) Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res 13: 187-194.
23. Benimetskaya L, Takle GB, Vilenchik M, Lebedeva I, Miller P, et al. (1998) Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Res 26: 5310-5317.
24. Fertil B, Dertinger H, Courdi A, Malaise EP, (1984) Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 99: 73-84.
25. Song X, Tao YG, Deng XY, Jin X, Tan YN, et al. (2004) Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. Cell Signal 16: 1153-1162.
26. Hatzivassiliou E, Mosialos G, (2002) Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci 7: d319-329.
27. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103.
28. Liu HD, Zheng H, Li M, Hu DS, Tang M, et al. (2007) Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. Cell Signal 19: 419-427.
29. Yin L, Liao W, Deng X, Tang M, Gu H, et al. (2001) LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells. Chin Med J (Engl) 114: 718-722.
30. Wu BY, Woffendin C, MacLachlan I, Nabel GJ, (1997) Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev. J Virol 71: 3161-3167.
31. Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, et al. (2003) Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene 22: 2260-2271.
32. Pandita TK, (2003) A multifaceted role for ATM in genome maintenance. Expert Rev Mol Med 5: 1-21.
33. Gueven N, Keating KE, Chen P, Fukao T, Khanna KK, et al. (2001) Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia. J Biol Chem 276: 8884-8891.
34. Truman JP, Gueven N, Lavin M, Leibel S, Kolesnick R, et al. (2005) Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J Biol Chem 280: 23262-23272.
35. Ahmed KM, Li JJ, (2008) NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med 44: 1-13.
36. Zheng H, Li LL, Hu DS, Deng XY, Cao Y, (2007) Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 4: 185-196.
37. Li HP, Chang YS, (2003) Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 10: 490-504.
38. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, et al. (2007) Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970-1978.
39. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS, (2008) Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 82: 3654-3664.
40. Jung M, Zhang Y, Lee S, Dritschilo A, (1995) Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 268: 1619-1621.
41. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S, (2006) Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311: 1141-1146.
42. Ahmed KM, Nantajit D, Fan M, Murley JS, Grdina DJ, et al. (2009) Coactivation of ATM/ERK/NF-kappaB in the low-dose radiation-induced radioadaptive response in human skin keratinocytes. Free Radic Biol Med 46: 1543-1550.
43. De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, et al. (2009) Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis. Cell Cycle 8: 2093-2100.
44. Gruhne B, Sompallae R, Masucci MG, (2009) Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 28: 3997-4008.
45. Bose S, Yap LF, Fung M, Starzcynski J, Saleh A, et al. (2009) The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol 217: 345-352.